Trials Should Deal With Coverage Concerns Sooner, Study Says
Drugmakers’ health economics and outcomes research teams must provide earlier input on clinical trials so the data they generate have a better chance of securing reimbursement for treatments following regulatory approval, a new study concludes.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.